AUA2019 023IC - Chemotherapy And Immunotherapy Options For Genitourinary Malignancies
AUAUniversity6 Jun 2019

AUA2019 023IC - Chemotherapy And Immunotherapy Options For Genitourinary Malignancies

Support provided by independent educational grants from AbbVie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Genomic Health, Genentech, Merck, Pfizer, Inc. and Sanofi Genzyme CME Available: https://auau.auanet.org/content/chemo... Instructional Course Director(s) Costas Lallas, MD Thomas Jefferson University Hospital Instructional Course Faculty(s) Anne Calvaresi, DNP, CRNP Thomas Jefferson University Edouard Trabulsi, MD, FACS Sidney Kimmel Medical College at Thomas Jefferson University Review of current chemotherapy and immunotherapy regimens for genitourinary malignancies, including bladder, renal, prostate, and testis cancers. Indications, outcomes, and toxicities will be discussed as well as clinical trial concepts. Survivorship issues will also be a focus of the session, which will include short, direct didactic lectures as well as a question and answer period. Standard of care chemotherapy regimens (eg MVAC for urothelial carcinoma) as well as newer immunotherapy options (eg checkpoint inhibition for renal cell carcinoma) will be included. Session objectives will include familiarity with systemic therapy regimens for these malignancies as well as their specific expected outcomes and side effects. Learning Objectives: Describe the standard of care chemotherapy regimens for genitourinary malignancies Recall both historic and newer immunotherapy options in the treatment of genitourinary malignancies, including recently approved checkpoint inhibitors and antibody-drug conjugates. Outline the mechanism of action of common chemotherapy and immunotherapy regimens for genitourinary malignancies. Recognize and manage the adverse events related to these agents. Identify the survivorship issues surrounding patients on systemic treatments for genitourinary malignancies. List both completed and accruing clinical trials that are defining the paradigms of chemotherapy and immunotherapy use in genitourinary malignancies.

Episoder(428)

AUA2026: Advanced Cystoscopy Training for APPs

AUA2026: Advanced Cystoscopy Training for APPs

AUA2026: Advanced Cystoscopy Training for APPs Host: Mark L. Gonzalgo, MD, PhD, MBA Guests: Brett Johnson, MD and Davis Viprakasit, MD, FACS Tune in to hear straight from the experts about our newes...

26 Mar 19min

LG-IR-NMIBC Treatment Landscape (Republished)

LG-IR-NMIBC Treatment Landscape (Republished)

LG-IR-NMIBC Treatment Landscape (Republished) Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Chad R. Ritch, MD, MBA, FACS CME Available: cme.auanet.org/URL/GUPOD251 ACKNOWLEDGEMENTS: Support provided ...

25 Mar 28min

NMIBC Treatment Landscape (Republished)

NMIBC Treatment Landscape (Republished)

NMIBC Treatment Landscape (Republished) Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Janet Kukreja, MD, MPH, FACS CME Available: https://cme.auanet.org/URL/GUPOD253 ACKNOWLEDGEMENTS: Support provide...

18 Mar 29min

MIBC Treatment Landscape (Republished)

MIBC Treatment Landscape (Republished)

MIBC Treatment Landscape (Republished) Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Jen-Jane Liu, MD, FACS CME Available: https://cme.auanet.org/URL/GUPOD252 ACKNOWLEDGEMENTS: Support provided by in...

11 Mar 24min

AUA2025: Key Takeaways: Bladder Cancer

AUA2025: Key Takeaways: Bladder Cancer

AUA2025: Key Takeaways: Bladder Cancer Presenters: Patrick Hensley, MD & Janet Kukreja, MD

4 Mar 23min

Update Series (2026) Lesson 5: Long-term Urinary Catheters: Their Role & Management of Complications

Update Series (2026) Lesson 5: Long-term Urinary Catheters: Their Role & Management of Complications

Update Series (2026) Lesson 5: Long-term Urinary Catheters: Their Role & Management of Complications Now in its 45th installment, the AUA Update Series is renowned for delivering high-quality lessons...

25 Feb 30min

Adjuvant Therapy for Renal Cell Carcinoma

Adjuvant Therapy for Renal Cell Carcinoma

Adjuvant Therapy for Renal Cell Carcinoma Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Daniel Shapiro, MD, FACS CME Available: https://cme.auanet.org/URL/RCCPOD261 ACKNOWLEDGEMENTS: Support provided...

18 Feb 25min

Use of Suction Ureteroscopes for Kidney Stone Treatment: CVAC System

Use of Suction Ureteroscopes for Kidney Stone Treatment: CVAC System

Use of Suction Ureteroscopes for Kidney Stone Treatment: CVAC System Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Karen L. Stern, MD

11 Feb 14min

Populært innen Fakta

fastlegen
dine-penger-pengeradet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
foreldreradet
rss-strid-de-norske-borgerkrigene
treningspodden
jakt-og-fiskepodden
rss-sunn-okonomi
sinnsyn
mikkels-paskenotter
takk-og-lov-med-anine-kierulf
hverdagspsyken
gravid-uke-for-uke
rss-kunsten-a-leve
tomprat-med-gunnar-tjomlid
hagespiren-podcast
rss-bisarr-historie
rss-var-forste-kaffe
fryktlos
rss-kull